Suppr超能文献

当前样本量约定:缺陷、危害及替代方案。

Current sample size conventions: flaws, harms, and alternatives.

机构信息

Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA.

出版信息

BMC Med. 2010 Mar 22;8:17. doi: 10.1186/1741-7015-8-17.

Abstract

BACKGROUND

The belief remains widespread that medical research studies must have statistical power of at least 80% in order to be scientifically sound, and peer reviewers often question whether power is high enough.

DISCUSSION

This requirement and the methods for meeting it have severe flaws. Notably, the true nature of how sample size influences a study's projected scientific or practical value precludes any meaningful blanket designation of <80% power as "inadequate". In addition, standard calculations are inherently unreliable, and focusing only on power neglects a completed study's most important results: estimates and confidence intervals. Current conventions harm the research process in many ways: promoting misinterpretation of completed studies, eroding scientific integrity, giving reviewers arbitrary power, inhibiting innovation, perverting ethical standards, wasting effort, and wasting money. Medical research would benefit from alternative approaches, including established value of information methods, simple choices based on cost or feasibility that have recently been justified, sensitivity analyses that examine a meaningful array of possible findings, and following previous analogous studies. To promote more rational approaches, research training should cover the issues presented here, peer reviewers should be extremely careful before raising issues of "inadequate" sample size, and reports of completed studies should not discuss power.

SUMMARY

Common conventions and expectations concerning sample size are deeply flawed, cause serious harm to the research process, and should be replaced by more rational alternatives.

摘要

背景

人们普遍认为,医学研究必须具有至少 80%的统计效力,才能在科学上站得住脚,因此同行评审员经常质疑效力是否足够高。

讨论

这一要求以及满足要求的方法存在严重缺陷。值得注意的是,样本量如何影响研究的预期科学或实际价值的本质,使任何将<80%的效力“不足”作为一概而论的做法都没有意义。此外,标准计算方法本质上不可靠,而只关注效力则忽略了已完成研究最重要的结果:估计值和置信区间。现行惯例在许多方面对研究过程造成损害:导致对已完成研究的误解、侵蚀科学诚信、赋予评审员任意的权力、阻碍创新、歪曲伦理标准、浪费精力和金钱。医学研究可以从替代方法中受益,包括已确立的信息价值方法、最近已得到合理证明的基于成本或可行性的简单选择、检查各种可能发现结果的敏感性分析,以及遵循先前类似的研究。为了促进更合理的方法,研究培训应涵盖这里提出的问题,同行评审员在提出“样本量不足”问题之前应极其谨慎,已完成研究的报告不应讨论效力。

总结

关于样本量的常见惯例和预期存在严重缺陷,对研究过程造成严重损害,应代之以更合理的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ed/2856520/e55ce281f755/1741-7015-8-17-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验